Collegium Pharmaceutical Inc Sustainability Reports
A specialty biopharmaceutical company that develops and commercializes medications for pain management and neuropsychiatry.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930049FXZMTLW8D496
FIGI: BBG001T535S9
8 reports from 2015 to 2025
